Parecoxib 40 Macleods


IV/IM powder for solution for injection
scheduling status
S3
registration number
57/2.9/0737.736
What Parecoxib 40 Macleods contains
Each 5 mL vial contains 40 mg parecoxib (as 42,36 mg lyophilised parecoxib sodium). After reconstitution with 2 mL sodium chloride intravenous infusion (0,9 % m/v), the concentration of parecoxib is 20 mg/mL.
other ingredients
Dibasic sodium phosphate Phosphoric acid and/or sodium hydroxide (if required for pH adjustment) Sugar Free Contains sodium.
Therapeutic classification
Anti-inflammatory and antirheumatic products (M01).
© 2026 SAHPRA. ALL RIGHTS RESERVED